Chikungunya is a mosquito-borne viral infection caused by the chikungunya virus (CHIKV), transmitted through the bite of Aedes aegypti and Aedes albopictus mosquitoes. India has experienced several large outbreaks and both urban and rural populations across the country remain at risk during and after monsoon periods. Most people with chikungunya recover fully within one to two weeks though severe joint pain can persist for months. A minority develop serious complications like neurological involvement, cardiac effects and severe dehydration that require emergency hospital care. Recognising these warning signs early can prevent lasting harm.

What Is Chikungunya?

Chikungunya is an acute viral arthropod-borne illness characterised by abrupt fever onset and polyarthralgia (pain affecting multiple joints simultaneously). The name chikungunya derives from a word in the Kimakonde language meaning 'to become contorted', describing the stooped posture that severe joint pain produces in affected patients.

Unlike dengue which the infection closely resembles in its initial days chikungunya rarely causes dangerous plasma leakage or thrombocytopaenia (dangerously low platelet counts). The dominant and often most debilitating feature is joint pain rather than haemorrhagic or vascular complications. Vertical transmission from mother to newborn during delivery is possible and produces a particularly severe form of the illness in neonates, with a high risk of neurological complications; this makes chikungunya in late pregnancy a clinical situation requiring close monitoring.

Common Causes of Chikungunya

The virus spreads through the bite of infected female Aedes mosquitoes, with no direct person to person transmission. Aedes aegypti and Aedes albopictus both serve as competent vectors. These species bite predominantly during daylight hours, meaning standard night-time mosquito protection is insufficient.

Standing water around homes like in flower pots, water storage containers, and discarded tyres provides the breeding sites these mosquitoes require. The risk of chikungunya transmission is therefore directly linked to local mosquito density. There is no vaccine against chikungunya currently approved for widespread use in India; immunity after natural infection is generally considered lifelong for the same strain but a second episode caused by a different strain remains theoretically possible.

Epidemic outbreaks in India occur with a broadly seasonal pattern, peaking during and after the monsoon when standing water is most abundant and Aedes mosquito populations are at their highest.

Signs and Symptoms of Chikungunya

The classic presentation is distinctive enough to be clinically recognised even before laboratory confirmation is available:

Abrupt high fever typically above 39°C arriving suddenly within two to four days of a mosquito bite marks the onset and generally resolves within three to five days.
Polyarthralgia is the hallmark feature and what makes this infection particularly disabling: joints of the hands, wrists, ankles, and feet are most commonly affected, and the pain is often severe enough to prevent normal walking or use of the hands.
A maculopapular rash (flat red spots that may become slightly raised) appears in approximately half of cases, typically on the trunk and limbs and is useful for clinical differentiation from dengue when the two are difficult to distinguish on fever pattern alone.
Headache, muscle aches, fatigue and eye pain (retro-orbital discomfort) are common accompanying symptoms.
Conjunctivitis and mild photophobia occur in many patients.
In a minority of patients particularly older adults and those with pre-existing conditions neurological, cardiac, or hepatic complications develop; these transform chikungunya from a self-limiting illness into an emergency.

When Should You Seek Emergency Care for Chikungunya?

For most patients, chikungunya is managed at home with rest, fluids and pain relief. Emergency assessment becomes necessary when any of the following appear:

Fever persisting beyond five days, or a fever that subsides and then returns
Neurological features like confusion, altered consciousness, severe headache with neck stiffness, seizures, or weakness in a limb develop with fever
Difficulty breathing or chest pain developing during the illness
Inability to retain any fluids, a very rapid heart rate, marked dizziness on standing or very little urine
Any chikungunya illness in a neonate or a pregnant woman near term should be assessed promptly, given the higher risk of severe or complicated disease in both groups.

Emergency Treatment at the Hospital for Chikungunya

No antiviral medication is currently available specifically for chikungunya so hospital treatment is entirely supportive and complication-directed.

Intravenous fluid resuscitation corrects dehydration and maintains circulatory stability in patients who cannot keep fluid down or who show haemodynamic compromise.
Pain management is a central treatment priority: analgesics during the acute phase; NSAIDs are avoided until dengue is confidently excluded, given the risk of exacerbating bleeding in that condition; they may be used carefully afterwards if joint pain is severe and dengue has been ruled out.
Neurological complications including chikungunya encephalitis are managed with intensive care support, close monitoring for raised intracranial pressure and anticonvulsant medication for seizure control. Corticosteroids are sometimes used in severe encephalitis, though evidence for this remains limited.
Cardiac monitoring and rhythm management are required in patients who develop myocarditis or arrhythmia; most cases of chikungunya-associated cardiac involvement are self-limiting with supportive care though the occasional patient requires antiarrhythmic treatment or temporary pacing.

Conclusion

Chikungunya is rarely fatal in otherwise healthy adults, but it is capable of producing debilitating joint pain that lasts weeks to months, and in vulnerable groups like neonates, older adults, pregnant women and those with chronic conditions serious complications can develop rapidly. Prolonged fever, neurological symptoms, difficulty breathing or an inability to keep fluids down are not features to wait out at home. Emergency assessment and supportive hospital care, started before significant deterioration occurs, give the best chance of an uncomplicated recovery.

FAQs

1. What are the warning signs that chikungunya has become serious?

Fever persisting beyond five days, confusion or altered consciousness, breathing difficulty, chest pain, severe dehydration or any neurological symptom alongside chikungunya all are warning signs.

2. What should I do if I have severe joint pain with chikungunya?

Rest the affected joints, take medicine for pain relief, stay well hydrated and contact a doctor if pain is severe enough to prevent normal function or if accompanied by any other warning features.

3. Can persistent high fever indicate a chikungunya emergency?

Chikungunya fever usually resolves within three to five days. Fever persisting more than this or returning after treatment indicates a complication and needs investigation.

4. Can chikungunya cause severe dehydration?

Yes high fever, sweating and reduced fluid intake during a painful illness can produce significant dehydration, particularly in children and older adults. Intravenous fluids are required when oral intake is insufficient.

5. What symptoms require immediate hospitalisation for chikungunya?

Confusion, seizures, difficulty breathing, chest pain, inability to retain any fluid, signs of severe dehydration or chikungunya illness in a neonate all require immediate hospitalisation rather than home management.

6. What emergency tests are performed for chikungunya?

RT-PCR (reverse transcriptase polymerase chain reaction) in the first five days or IgM serology after day five confirms chikungunya. Full blood count, kidney and liver function and ECG are performed to assess complications.

7. How is chikungunya diagnosed in the emergency department?

Diagnosis combines the clinical picture (abrupt fever, severe polyarthralgia and rash) with specific blood tests. RT-PCR in the early phase and IgM antibody testing after day five are the laboratory standards.

8. What treatments are available for severe chikungunya?

No specific antiviral exists. Treatment is supportive including intravenous fluids for dehydration, medicine for fever and pain, intensive care for encephalitis and cardiac monitoring for myocarditis or arrhythmia.

9. What complications can occur if chikungunya is left untreated?

Severe dehydration, chikungunya encephalitis, myocarditis, hepatitis, uveitis (eye inflammation) and persistent post-chikungunya arthritis lasting weeks to months are the main complications. Neonates face a particularly high risk of severe neurological disease.

10. What should I avoid doing while recovering from chikungunya?

Avoid ibuprofen and aspirin until dengue is excluded, avoid vigorous exercise while joints are acutely inflamed, avoid dehydration by maintaining fluid intake even when unwell and avoid delaying assessment if warning features appear.

11. How long does recovery from severe chikungunya take?

In most patients acute fever resolves within three to five days. Joint pain improves over weeks but can persist for three to six months or occasionally longer. Neurological complications have the most variable recovery timeline.

12. When should I follow up with a doctor after emergency treatment for chikungunya?

Follow up care is necessary to ensure a complete recovery. A doctor's review within one week after discharge confirm that the infection & its immediate complications have resolved. Patients with persistent joint pain should be followed at one month and those with neurological or cardiac involvement need ongoing follow up.